These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26970283)

  • 1. Development of a nanosuspension for iv administration: From miniscale screening to a freeze dried formulation.
    Frank KJ; Boeck G
    Eur J Pharm Sci; 2016 May; 87():112-7. PubMed ID: 26970283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling.
    Medarević D; Djuriš J; Ibrić S; Mitrić M; Kachrimanis K
    Int J Pharm; 2018 Apr; 540(1-2):150-161. PubMed ID: 29438724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
    Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active freeze drying for production of nanocrystal-based powder: A pilot study.
    Touzet A; Pfefferlé F; der Wel PV; Lamprecht A; Pellequer Y
    Int J Pharm; 2018 Jan; 536(1):222-230. PubMed ID: 29175644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers.
    Wang L; Ma Y; Gu Y; Liu Y; Zhao J; Yan B; Wang Y
    J Microencapsul; 2018 May; 35(3):241-248. PubMed ID: 29624090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
    Du B; Li XT; Zhao Y; A YM; Zhang ZZ
    Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distribution.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2011 May; 100(5):1958-68. PubMed ID: 21374626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of nanosuspensions in drug delivery.
    Wang Y; Zheng Y; Zhang L; Wang Q; Zhang D
    J Control Release; 2013 Dec; 172(3):1126-41. PubMed ID: 23954372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
    Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
    Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.
    Yang X; Miao X; Cao F; Li S; Ai N; Chang Q; Lee SMY; Zheng Y
    J Pharm Sci; 2014 Nov; 103(11):3576-3584. PubMed ID: 25187229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
    Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
    Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
    Niwa T; Danjo K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):272-81. PubMed ID: 23907001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosuspension formulations of poorly water-soluble compounds for intravenous administration in exploratory toxicity studies: in vitro and in vivo evaluation.
    Fujimura H; Komasaka T; Tomari T; Kitano Y; Takekawa K
    J Appl Toxicol; 2016 Oct; 36(10):1259-67. PubMed ID: 26849104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization.
    Gol D; Thakkar S; Misra M
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1458-1466. PubMed ID: 29619857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound.
    Ain-Ai A; Gupta PK
    Int J Pharm; 2008 Mar; 351(1-2):282-8. PubMed ID: 18036751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation aspects of intravenous nanosuspensions.
    Patel D; Zode SS; Bansal AK
    Int J Pharm; 2020 Aug; 586():119555. PubMed ID: 32562654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of freeze-drying in the development of oral drug delivery systems.
    Siow CR; Wan Sia Heng P; Chan LW
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1595-1608. PubMed ID: 27267745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.